(Q41056884)

English

Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen (English)

1 reference

Europe PubMed Central

26 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cheng AL

1

1 reference

Europe PubMed Central

26 September 2017

Chuang SE

2

1 reference

Europe PubMed Central

26 September 2017

Fine RL

3

1 reference

Europe PubMed Central

26 September 2017

Yeh KH

4

1 reference

Europe PubMed Central

26 September 2017

Liao CM

5

1 reference

Europe PubMed Central

26 September 2017

Lay JD

6

1 reference

Europe PubMed Central

26 September 2017

Chen DS

7

1 reference

Europe PubMed Central

26 September 2017

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

26 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

26 September 2017

55

1 reference

Europe PubMed Central

26 September 2017

523-531

1 reference

Europe PubMed Central

26 September 2017

4

1 reference

Europe PubMed Central

26 September 2017

Clinical trials in primary hepatocellular carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

A rapid and simple method for the isolation of apoptotic DNA fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of "failed" patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Tamoxifen in the treatment of refractory lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900594-7

7 January 2021

Identifiers

10.1016/S0006-2952(97)00594-7

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41056884&oldid=1962128214"